All stock lists
MercadoLibre, Inc. (NASDAQ:MELI)
UY · Delayed Price · Currency is USD
Also listed: 0K0E.L, MLB1.DEConsumer Cyclical · Specialty Retail
1668.72-141.43 (-7.81%)
Market cap
$84.6B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 10, 2007
Website
Insider Score
––Not scored
MELI Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From MELI’s reported statements · Q2 2026 (trailing 12 months)
Profitability13 / 20
Profitable, but on a thin margin.
- Revenue
- $35.18B
- Net income
- $1.86B
- Net margin
- 5.3%
Leverage6 / 20
Heavily indebted for what it earns.
- Total debt
- $13.18B
- Cash
- $3.65B
- Net debt / EBITDA
- 2.81x
Liquidity8 / 20
Covers near-term obligations, without much room.
- Current assets
- $40.78B
- Current liabilities
- $36.37B
- Current ratio
- 1.12
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $13.16B
- Free cash flow
- $11.75B
- FCF margin
- 33.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 50.7M
- Share growth (1y)
- -0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MELI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 10.17 B | 8.85 B | 8.76 B | 7.41 B | 6.79 B | 5.93 B |
| Revenue Growth (YoY) | 49.76 % | 49.03 % | 44.56 % | 39.48 % | 33.85 % | 36.97 % |
| Cost of Revenue | 6.01 B | 4.98 B | 4.97 B | 4.20 B | 3.70 B | 3.16 B |
| Gross Profit | 4.16 B | 3.86 B | 3.78 B | 3.21 B | 3.09 B | 2.77 B |
| SG&A Expense | 1.47 B | -656.00 M | 1.33 B | -563.00 M | 1.01 B | 854.00 M |
| R&D Expense | 729.00 M | 699.00 M | 584.00 M | 567.00 M | 567.00 M | 551.00 M |
| Operating Expenses | 3.48 B | 3.25 B | 2.90 B | 2.48 B | 2.27 B | 2.01 B |
| Operating Income | 683.00 M | 611.00 M | 889.00 M | 724.00 M | 825.00 M | 763.00 M |
| Pretax Income | 606.00 M | 579.00 M | 784.00 M | 241.00 M | 716.00 M | 706.00 M |
| Tax Provision | 140.00 M | 162.00 M | 225.00 M | -215.00 M | 193.00 M | 212.00 M |
| Net Income | 466.00 M | 417.00 M | 559.00 M | 421.00 M | 523.00 M | 494.00 M |
| EPS (Basic) | 9.19 | 8.23 | 11.03 | 8.30 | 10.32 | 9.74 |
| EPS (Diluted) | 9.19 | 8.23 | 11.03 | 8.30 | 10.32 | 9.74 |
| Shares Outstanding | 50.70 M | 50.70 M | 50.70 M | 50.70 M | 50.70 M | 50.70 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.